Incidence of hospital readmission in patients diagnosed withDVTandPE: clinical burden of recurrent events
Open Access
- 14 November 2014
- journal article
- Published by Hindawi Limited in International Journal of Clinical Practice
- Vol. 69 (3), 321-327
- https://doi.org/10.1111/ijcp.12519
Abstract
Venous thromboembolism (VTE), which comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE), is associated with significant morbidity and mortality and represents a considerable economic burden to the US healthcare system. Although it is well established that patients with an initial VTE are at increased risk for recurrent VTE, limited data exist on the clinical burden of a secondary DVT or PE event. The objective of this retrospective observational study was to conduct an epidemiologic evaluation, from a hospital perspective, of patients with an initial DVT or PE who experienced a recurrent event postdischarge requiring hospital readmission.Hospital claims containing DVT or PE as a primary diagnosis for hospitalisation during the period October 2009 to April 2013 were identified by retrospective analysis using the MarketScan database. The time to hospital readmission for DVT or PE was assessed using the MarketScan Treatment Pathways tool.Of 214,901 patient admissions identified with a diagnosis of DVT or PE at hospital admission, approximately 4% were subsequently readmitted to the hospital with a diagnosis of PE (8217) or DVT (9138). Of all readmitted patients with a diagnosis of DVT on initial admission, 66% were rehospitalised with a diagnosis of DVT, and 34% were rehospitalised with a diagnosis of PE. Of all readmitted patients with a diagnosis of PE on initial admission, 63% were rehospitalised with a diagnosis of PE and 37% with a diagnosis of DVT. Of all hospital readmissions with a diagnosis of PE or DVT, 62% and 58% occurred within the first 30 days following an initial PE or DVT event, respectively.The burden of DVT or PE is large, not only because of the initial hospitalisation event but also because of the high number of hospital readmissions, more than half of which occur within 30 days.Keywords
Funding Information
- Janssen Scientific Affairs
This publication has 13 references indexed in Scilit:
- Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort studyBlood, 2011
- Clinical burden of venous thromboembolismCurrent Medical Research and Opinion, 2010
- Use of Emerging Oral Anticoagulants in Clinical PracticeAnnals of Surgery, 2009
- HOSPITAL READMISSION AND ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM: FROM A HEALTH PLAN PERSPECTIVESocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During HospitalizationJournal of Managed Care Pharmacy, 2005
- Prevention of Venous ThromboembolismSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2004
- Management of Patients with Acute Venous Thromboembolism: Findings from the RIETE RegistryPathophysiology of Haemostasis and Thrombosis, 2003
- Natural History of Venous ThromboembolismCirculation, 2003
- Management of Deep Vein Thrombosis and Pulmonary EmbolismCirculation, 1996